1Hans CP, Weisenburger DD, Greiner TC, et al. Confirma- tion of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue mi- croarray [-J. Blood, 2004,103 (1) : 275-282.
5Iqbal J, Sanger WG, Horsman DE,et al. Bcl-2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma[J. Am J Pathol, 2004,165(1) . 159-166.
4Hunt KE, Reichard KK. Diffuse large B-cell lymphoma. Arch Pathol Lab Med, 2008, 132(1) :118-124.
5Coiffier B. Diffuse large cell lymphoma. Curr Opin Oncol, 2001, 13 (5) :325-334.
6Hans CP, Weisenberger D, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarry. Blood, 2003, 103 ( 1 ) :275-282.
7Lossos IS, Czerwinski DK, Alizadeh AA, et al. Prediction of survival in diffuse large B-cell lymphoma based on the expression of six genes. N Engl J Med, 2004, 350(18) :1828-1837.
8Offit K, Le Coco F, Louie DC, et al. Rearrangement of the BCL-6 gene as a prognostic marker in diffuse large cell lymphoma. N Engl J Med, 1994, 331(2) :74-80.
9Ueda C, Akasaka T, Ohno H. Non-immunoglobulin/BCL6 gene fusion in diffuse large B-cell lymphoma: prognostic implications. Leuk Lymphoma, 2002, 43 (7) : 1375-1381.
10Ohno H. Pathogenetic and clinical implications of immunoglobulin; BCL6 translocations in B-cell non-Hodgkin's lymphoma. J Clin Exp Hematop, 2006, 46(2) :43-53.
